Kevzara and Pustular psoriasis - a phase IV clinical study of FDA data

Summary:

Pustular psoriasis is reported as a side effect among people who take Kevzara (sarilumab), especially for people who are female, 40-49 old, also take Sulfasalazine, and have Crohn's disease.

The phase IV clinical study analyzes which people have Pustular psoriasis when taking Kevzara. It is created by eHealthMe based on reports of 17,556 people who have side effects when taking Kevzara from the FDA, and is updated regularly.

What is Kevzara?

Kevzara has active ingredients of sarilumab. eHealthMe is studying from 17,561 Kevzara users. Check the latest studies of Kevzara.

What is Pustular psoriasis?

Pustular psoriasis (raised bumps on the skin that are filled with pus) is found to be associated with 257 drugs and 416 conditions by eHealthMe. Check the latest studies of Pustular psoriasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

17,556 people reported to have side effects when taking Kevzara.
Among them, 17 people (0.1%) have Pustular psoriasis.

Among these 17 people:

What is the gender of people who have Pustular psoriasis when taking Kevzara? *

female: 100 %
male: 0.0 %

What is the age of people who have Pustular psoriasis when taking Kevzara? *

What are other drugs people take besides Kevzara? *

Acetaminophen: 17 people, 100.00%
Periogard: 17 people, 100.00%
Rituxan: 17 people, 100.00%
Simponi: 17 people, 100.00%
Cosentyx: 17 people, 100.00%
Prednisone: 17 people, 100.00%
Stelara: 17 people, 100.00%
Sulfamethoxazole: 17 people, 100.00%
Cetirizine Hydrochloride: 17 people, 100.00%
Sulfasalazine: 17 people, 100.00%

What are other side effects people have besides Pustular psoriasis? *

X-Ray Abnormal: 17 people, 100.00%
Rash Vesicular (rash with a small bubble): 17 people, 100.00%
Back Disorder: 17 people, 100.00%
Drug Hypersensitivity: 17 people, 100.00%
Fever: 17 people, 100.00%
Fluid Retention (an abnormal accumulation of fluid in the blood): 17 people, 100.00%
Folliculitis (infection of hair root): 17 people, 100.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 17 people, 100.00%
General Symptom: 17 people, 100.00%
Ill-Defined Disorder: 17 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 17 people, 100.00%
Psoriasis (immune-mediated disease that affects the skin): 17 people, 100.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 17 people, 100.00%
Ankylosing Spondylitis (type of arthritis affecting the spine): 16 people, 94.12%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 14 people, 82.35%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 14 people, 82.35%
Stress And Anxiety: 3 people, 17.65%
Arthropathy: 3 people, 17.65%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.88%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Kevzara and have Pustular psoriasis?

- Check whether Pustular psoriasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kevzara:

Kevzara (17,561 reports)

Browse all side effects of Kevzara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pustular psoriasis:

Pustular psoriasis (257 drugs)

Browse all the conditions that are associated with Pustular psoriasis:

Pustular psoriasis (416 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sarilumab (the active ingredients of Kevzara) and Kevzara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.